Global Information
회사소개 | 문의 | 비교리스트

세계의 헤지호그 경로 억제제 시장(2022-2026년)

Global Hedgehog Pathway Inhibitors Market 2022-2026

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2022년 07월 상품코드 1107645
페이지 정보 영문 120 Pages 배송안내
가격
US $ 2,500 ₩ 3,276,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 5,242,000 PDF (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 헤지호그 경로 억제제 시장(2022-2026년) Global Hedgehog Pathway Inhibitors Market 2022-2026
발행일 : 2022년 07월 페이지 정보 : 영문 120 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 헤지호그 경로 억제제 시장 규모는 2022-2026년간 3억 8,552만 달러의 증가가 전망되며, 예측기간 중 13%의 CAGR로 성장할 것으로 예측됩니다.

시장 성장을 촉진하는 주요 요인으로 기저세포암(BCC)·급성 골수성 백혈병(AML)의 고위험요인, 노년 인구 증가, 기저세포암(BCC)·급성 골수성 백혈병(AML)에 대한 관심 상승을 들 수 있습니다.

세계의 헤지호그 경로 억제제(Hedgehog Pathway Inhibitors) 시장에 대해 조사 분석했으며, 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제 및 약 25개사 벤더를 커버하는 벤더 분석을 제공합니다.

목차

제1장 주요 요약

  • 시장 개요

제2장 시장 상황

  • 시장 생태계

제3장 시장 규모

  • 시장 정의
  • 시장 부문 분석
  • 시장 규모(2021년)
  • 시장 전망 : 2021-2026년 예측

제4장 Five Forces 분석

  • Five Forces 요약
  • 구매자의 협상력
  • 공급 기업의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 상황

제5장 적응증별 시장 세분화

  • 시장 부문
  • 적응증별 비교
  • 기저세포암(BCC) : 시장 규모와 예측(2021-2026년)
  • 급성 골수성 백혈병(AML) : 시장 규모와 예측(2021-2026년)
  • 적응증별 시장 기회

제6장 고객 상황

  • 고객 상황 개요

제7장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2021-2026년)
  • 유럽 : 시장 규모와 예측(2021-2026년)
  • 아시아 : 시장 규모와 예측(2021-2026년)
  • 기타 지역(ROW) : 시장 규모와 예측(2021-2026년)
  • 미국 : 시장 규모와 예측(2021-2026년)
  • 캐나다 : 시장 규모와 예측(2021-2026년)
  • 독일 : 시장 규모와 예측(2021-2026년)
  • 영국 : 시장 규모와 예측(2021-2026년)
  • 중국 : 시장 규모와 예측(2021-2026년)
  • 지역 상황별 시장 기회

제8장 성장 촉진요인, 과제, 동향

  • 시장 성장 촉진요인
  • 시장 과제
  • 성장 촉진요인과 과제의 영향
  • 시장 동향

제9장 벤더 상황

  • 개요
  • 벤더 상황
  • 혼란 상황
  • 업계 위험

제10장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • BridgeBio Pharma Inc.
  • Bristol Myers Squibb Co.
  • F. Hoffmann La Roche Ltd.
  • Inhibitor Therapeutics Inc
  • MAX BioPharma Inc.
  • Mayne Pharma Group Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.

제11장 부록

KSM 22.08.04

Technavio has been monitoring the hedgehog pathway inhibitors market and it is poised to grow by $ 385.52 mn during 2022-2026, accelerating at a CAGR of 13% during the forecast period. Our report on the hedgehog pathway inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high-risk factors for BCC and AML, the growth of the geriatric population, and increasing awareness about BCC and AML.

The hedgehog pathway inhibitors market analysis includes the indication segment and geographic landscape.

Technavio's hedgehog pathway inhibitors market is segmented as below:

By Indication

  • BCC
  • AML

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the development of repurposed formulations as one of the prime reasons driving the hedgehog pathway inhibitors market growth during the next few years. Also, strategic alliances and funding for cancer-related research will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the hedgehog pathway inhibitors market covers the following areas:

  • Hedgehog pathway inhibitors market sizing
  • Hedgehog pathway inhibitors market forecast
  • Hedgehog pathway inhibitors market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hedgehog pathway inhibitors market vendors that include Bristol Myers Squibb Co., Infinity Pharmaceuticals Inc., F. Hoffmann La Roche Ltd., Inhibitor Therapeutics Inc, MAX BioPharma Inc., Mayne Pharma Group Ltd., Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and BridgeBio Pharma Inc. Also, the hedgehog pathway inhibitors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Indication
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Indication

  • 5.1 Market segments
  • Exhibit 24: Chart on Indication - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Indication - Market share 2021-2026 (%)
  • 5.2 Comparison by Indication
  • Exhibit 26: Chart on Comparison by Indication
  • Exhibit 27: Data Table on Comparison by Indication
  • 5.3 BCC - Market size and forecast 2021-2026
  • Exhibit 28: Chart on BCC - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on BCC - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on BCC - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on BCC - Year-over-year growth 2021-2026 (%)
  • 5.4 AML - Market size and forecast 2021-2026
  • Exhibit 32: Chart on AML - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on AML - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on AML - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on AML - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Indication
  • Exhibit 36: Market opportunity by Indication ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Canada - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.9 Germany - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.10 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.11 China - Market size and forecast 2021-2026
  • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 BridgeBio Pharma Inc.
  • Exhibit 85: BridgeBio Pharma Inc. - Overview
  • Exhibit 86: BridgeBio Pharma Inc. - Product / Service
  • Exhibit 87: BridgeBio Pharma Inc. - Key news
  • Exhibit 88: BridgeBio Pharma Inc. - Key offerings
  • 10.4 Bristol Myers Squibb Co.
  • Exhibit 89: Bristol Myers Squibb Co. - Overview
  • Exhibit 90: Bristol Myers Squibb Co. - Product / Service
  • Exhibit 91: Bristol Myers Squibb Co. - Key offerings
  • 10.5 F. Hoffmann La Roche Ltd.
  • Exhibit 92: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 93: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 94: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 95: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 96: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.6 Inhibitor Therapeutics Inc
  • Exhibit 97: Inhibitor Therapeutics Inc - Overview
  • Exhibit 98: Inhibitor Therapeutics Inc - Product / Service
  • Exhibit 99: Inhibitor Therapeutics Inc - Key offerings
  • 10.7 MAX BioPharma Inc.
  • Exhibit 100: MAX BioPharma Inc. - Overview
  • Exhibit 101: MAX BioPharma Inc. - Product / Service
  • Exhibit 102: MAX BioPharma Inc. - Key offerings
  • 10.8 Mayne Pharma Group Ltd.
  • Exhibit 103: Mayne Pharma Group Ltd. - Overview
  • Exhibit 104: Mayne Pharma Group Ltd. - Business segments
  • Exhibit 105: Mayne Pharma Group Ltd. - Key news
  • Exhibit 106: Mayne Pharma Group Ltd. - Key offerings
  • Exhibit 107: Mayne Pharma Group Ltd. - Segment focus
  • 10.9 Novartis AG
  • Exhibit 108: Novartis AG - Overview
  • Exhibit 109: Novartis AG - Business segments
  • Exhibit 110: Novartis AG - Key offerings
  • Exhibit 111: Novartis AG - Segment focus
  • 10.10 Pfizer Inc.
  • Exhibit 112: Pfizer Inc. - Overview
  • Exhibit 113: Pfizer Inc. - Product / Service
  • Exhibit 114: Pfizer Inc. - Key news
  • Exhibit 115: Pfizer Inc. - Key offerings
  • 10.11 Sanofi
  • Exhibit 116: Sanofi - Overview
  • Exhibit 117: Sanofi - Business segments
  • Exhibit 118: Sanofi - Key news
  • Exhibit 119: Sanofi - Key offerings
  • Exhibit 120: Sanofi - Segment focus
  • 10.12 Sun Pharmaceutical Industries Ltd.
  • Exhibit 121: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibit 122: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibit 123: Sun Pharmaceutical Industries Ltd. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 124: Inclusions checklist
  • Exhibit 125: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 126: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 127: Research methodology
  • Exhibit 128: Validation techniques employed for market sizing
  • Exhibit 129: Information sources
  • 11.5 List of abbreviations
  • Exhibit 130: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Indication - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Indication - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Indication
  • Exhibits27: Data Table on Comparison by Indication
  • Exhibits28: Chart on BCC - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on BCC - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on BCC - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on BCC - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on AML - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on AML - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on AML - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on AML - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Indication ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: BridgeBio Pharma Inc. - Overview
  • Exhibits86: BridgeBio Pharma Inc. - Product / Service
  • Exhibits87: BridgeBio Pharma Inc. - Key news
  • Exhibits88: BridgeBio Pharma Inc. - Key offerings
  • Exhibits89: Bristol Myers Squibb Co. - Overview
  • Exhibits90: Bristol Myers Squibb Co. - Product / Service
  • Exhibits91: Bristol Myers Squibb Co. - Key offerings
  • Exhibits92: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits93: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits94: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits95: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits96: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits97: Inhibitor Therapeutics Inc - Overview
  • Exhibits98: Inhibitor Therapeutics Inc - Product / Service
  • Exhibits99: Inhibitor Therapeutics Inc - Key offerings
  • Exhibits100: MAX BioPharma Inc. - Overview
  • Exhibits101: MAX BioPharma Inc. - Product / Service
  • Exhibits102: MAX BioPharma Inc. - Key offerings
  • Exhibits103: Mayne Pharma Group Ltd. - Overview
  • Exhibits104: Mayne Pharma Group Ltd. - Business segments
  • Exhibits105: Mayne Pharma Group Ltd. - Key news
  • Exhibits106: Mayne Pharma Group Ltd. - Key offerings
  • Exhibits107: Mayne Pharma Group Ltd. - Segment focus
  • Exhibits108: Novartis AG - Overview
  • Exhibits109: Novartis AG - Business segments
  • Exhibits110: Novartis AG - Key offerings
  • Exhibits111: Novartis AG - Segment focus
  • Exhibits112: Pfizer Inc. - Overview
  • Exhibits113: Pfizer Inc. - Product / Service
  • Exhibits114: Pfizer Inc. - Key news
  • Exhibits115: Pfizer Inc. - Key offerings
  • Exhibits116: Sanofi - Overview
  • Exhibits117: Sanofi - Business segments
  • Exhibits118: Sanofi - Key news
  • Exhibits119: Sanofi - Key offerings
  • Exhibits120: Sanofi - Segment focus
  • Exhibits121: Sun Pharmaceutical Industries Ltd. - Overview
  • Exhibits122: Sun Pharmaceutical Industries Ltd. - Product / Service
  • Exhibits123: Sun Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits124: Inclusions checklist
  • Exhibits125: Exclusions checklist
  • Exhibits126: Currency conversion rates for US$
  • Exhibits127: Research methodology
  • Exhibits128: Validation techniques employed for market sizing
  • Exhibits129: Information sources
  • Exhibits130: List of abbreviations
Back to Top
전화 문의
F A Q